These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. Kaiser PK Am J Ophthalmol; 2006 Oct; 142(4):660-8. PubMed ID: 17011860 [TBL] [Abstract][Full Text] [Related]
15. Treatment of diabetic retinopathy with anti-VEGF drugs. Waisbourd M; Goldstein M; Loewenstein A Acta Ophthalmol; 2011 May; 89(3):203-7. PubMed ID: 21044274 [TBL] [Abstract][Full Text] [Related]
16. Clinical update: new treatments for age-related macular degeneration. Wong TY; Liew G; Mitchell P Lancet; 2007 Jul; 370(9583):204-206. PubMed ID: 17658379 [No Abstract] [Full Text] [Related]
17. Treatment of neovascular age-related macular degeneration with pegaptanib and boosting with bevacizumab or ranibizumab as needed. Farah SE Ophthalmic Surg Lasers Imaging; 2008; 39(4):294-8. PubMed ID: 18717434 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Virgili G; Parravano M; Menchini F; Brunetti M Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642 [TBL] [Abstract][Full Text] [Related]
19. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ip MS; Scott IU; Brown GC; Brown MM; Ho AC; Huang SS; Recchia FM; Ophthalmology; 2008 Oct; 115(10):1837-46. PubMed ID: 18929163 [TBL] [Abstract][Full Text] [Related]
20. [The current state and issues of medical treatment for age-related macular degeneration]. Ishida S Nihon Yakurigaku Zasshi; 2008 Jan; 131(1):47-9. PubMed ID: 18187884 [No Abstract] [Full Text] [Related] [Next] [New Search]